Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ketrosden Triasmitra Tbk. (KETR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Ketrosden Triasmitra Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Ketrosden Triasmitra Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ketrosden Triasmitra Tbk. trades at Rp955 (market cap 2.64T, 92.24M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Ketrosden Triasmitra Tbk. is far larger — about 15.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Ketrosden Triasmitra Tbk. is more actively traded (92.24M versus 324K). Which is the better fit depends on your goals.

KETROBAT
Market Cap
2.64T166.01B
Volume
92.24M324K
Lot
922.38K3.24K
Turnover
90.37B77.68M
Average Price
979.8239.75
Value
90.37B77.68M
Indicative Equilibrium Price
955240
Indicative Equilibrium Volume
29.3K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KETR
View details
OBAT
View details

About Ketrosden Triasmitra Tbk.

PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.

Read more on KETR

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT